Literature DB >> 18274932

Polymeric nanoparticles for cancer therapy.

Suphiya Parveen1, Sanjeeb K Sahoo.   

Abstract

Cancer is an ever-increasing menace that needs to be curbed soon. Though chemotherapy is successful to some extent, the main drawbacks of chemotherapy is the limited accessibility of drugs to the tumor tissues requiring high doses, their intolerable toxicity, development of multiple drug resistance and their non-specific targeting. Nanoparticles (NPs), an evolution of nanotechnology, have the potential to successfully address these problems related to drug delivery and retention and are considered potential candidates to carry drugs to the desired site of therapeutic action. In this review, we give an overview of the use of clinically applicable NPs mainly for cancer therapy. We also focus on the different types of nanoscale polymer carriers used for the delivery of chemotherapeutic agents and the mechanisms that facilitate their targeted delivery to tumor cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274932     DOI: 10.1080/10611860701794353

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  59 in total

1.  Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.

Authors:  Debatosh Majumdar; Kyung-Ho Jung; Hongzheng Zhang; Sreenivas Nannapaneni; Xu Wang; A R M Ruhul Amin; Zhengjia Chen; Zhuo G Chen; Dong M Shin
Journal:  Cancer Prev Res (Phila)       Date:  2014-01

2.  Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Cancer Nanotechnol       Date:  2010-10-25

3.  Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.

Authors:  Yichao Wang; Puwang Li; Lingxue Kong
Journal:  AAPS PharmSciTech       Date:  2013-03-06       Impact factor: 3.246

Review 4.  Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.

Authors:  Anish Babu; Amanda K Templeton; Anupama Munshi; Rajagopal Ramesh
Journal:  AAPS PharmSciTech       Date:  2014-02-19       Impact factor: 3.246

5.  Carbon Dioxide-Generating PLG Nanoparticles for Controlled Anti-Cancer Drug Delivery.

Authors:  Hyeon Jin Jang; Eun Ju Jeong; Kuen Yong Lee
Journal:  Pharm Res       Date:  2018-02-09       Impact factor: 4.200

Review 6.  Cancer nanotechnology: emerging role of gold nanoconjugates.

Authors:  Rachel A Kudgus; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Anticancer Agents Med Chem       Date:  2011-12       Impact factor: 2.505

7.  Engineering building blocks for self-assembling protein nanoparticles.

Authors:  Esther Vázquez; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2010-12-30       Impact factor: 5.328

Review 8.  Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.

Authors:  Prashant Kesharwani; Arun K Iyer
Journal:  Drug Discov Today       Date:  2014-12-31       Impact factor: 7.851

Review 9.  Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy.

Authors:  Hadi Samadian; Samira Hosseini-Nami; Seyed Kamran Kamrava; Habib Ghaznavi; Ali Shakeri-Zadeh
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-21       Impact factor: 4.553

10.  Stoichiometry and Structure of Poly(amidoamine) Dendrimer-Lipid Complexes.

Authors:  Christopher V Kelly; Meghan G Liroff; L Devon Triplett; Pascale R Leroueil; Douglas G Mullen; Joseph M Wallace; Sasha Meshinchi; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  ACS Nano       Date:  2009-06-17       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.